Page last updated: 2024-10-24

carbamazepine and Hyperparathyroidism, Secondary

carbamazepine has been researched along with Hyperparathyroidism, Secondary in 2 studies

Carbamazepine: A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties.
carbamazepine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine carrying a carbamoyl substituent at the azepine nitrogen, used as an anticonvulsant.

Hyperparathyroidism, Secondary: Abnormally elevated PARATHYROID HORMONE secretion as a response to HYPOCALCEMIA. It is caused by chronic KIDNEY FAILURE or other abnormalities in the controls of bone and mineral metabolism, leading to various BONE DISEASES, such as RENAL OSTEODYSTROPHY.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mintzer, S1
Boppana, P1
Toguri, J1
DeSantis, A1
Andersen, RS1
Valeur, N1

Other Studies

2 other studies available for carbamazepine and Hyperparathyroidism, Secondary

ArticleYear
Vitamin D levels and bone turnover in epilepsy patients taking carbamazepine or oxcarbazepine.
    Epilepsia, 2006, Volume: 47, Issue:3

    Topics: Adolescent; Adult; Aged; Alkaline Phosphatase; Anticonvulsants; Biomarkers; Bone and Bones; Bone Res

2006
[Hyperparathyroidism secondary to anticonvulsant treatment].
    Ugeskrift for laeger, 2001, Nov-05, Volume: 163, Issue:45

    Topics: Alkaline Phosphatase; Anticonvulsants; Calcifediol; Carbamazepine; Female; Humans; Hyperparathyroidi

2001